Seasonal Affective Disorder Market Analysis by Top Vendors, Size, Revenue and Growth Rate
Seasonal affective disorder market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to growing at a CAGR of 5.30% in the above-mentioned forecast period. Broadening information amidst the doctors and inmates concerning the advantages and availability of equipment will assist in encouraging the growth of the market.
Seasonal affective disorder (SAD) is kind of depression that occurs during certain period of year according to changes in seasons, it mostly occur in winter and commonly found in women or people aged between 15 to 55 or the people who live far from equator where winter daylight hours are very short. Some of the symptoms are hopelessness, increased appetite, weight gain and loss of ability to focus, among others. Increasing awareness of this disorder will drive the market in the forecast period.
Increasing geriatric population with increasing awareness of seasonal affective disorder are the driving factors for the market. In addition, changing lifestyle and lack of exercise are also the key drivers for the market. Moreover, adoption of new treatments and medication will be beneficial for market in the forecast period. However, lack of skilled professionals and high treatment costs are restraining factor for market whereas lack of awareness about disorder can be challenge for market to expand.
Global Seasonal Affective Disorder Market Scope and Market Size
Seasonal affective disorder market is segmented on the basis of type, physical exam, treatment and end-use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.
- Based on type, seasonal affective disorder market is segmented into fall & winter (SAD), spring & summer (SAD), and others.
- Based on physical exam, seasonal affective disorder market is segmented into lab tests, psychological evaluation, and others. Lab tests are further segmented into CBC, thyroid blood test and others. Psychological evaluation is sub-segmented into intelligence tests, personality tests, attitude tests, achievement tests, aptitude tests, neuropsychological tests, vocational tests, direct observation tests and others.
- On the basis of treatment, the seasonal affective disorder market is segmented into light therapy, medications, psychotherapy, counselling, and others. Medications include antidepressants, and others. Antidepressants is further sub-segmented into reuptake inhibitors (SSRIs), and others. Psychotherapy includes art therapy, attachment-based psychotherapy, behavioral therapy, body psychotherapy, cognitive analytical therapy (CAT), existential psychotherapy, gestalt therapy, and others.
- Seasonal affective disorder market has also been segmented based onthe end use into hospitals, clinics, research institutes, and others.
Seasonal Affective Disorder Market Country Level Analysis
Seasonal affective disorder market is analysed and market size insights and trends are provided by country, type of test, physical exam, treatment, and end-use as referenced above.
The countries covered in the seasonal affective disorder market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.
Competitive Landscape and Seasonal Affective Disorder Market Share Analysis
Seasonal affective disordermarketcompetitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Seasonal Affective Disorder market.
The major players operating in the seasonal affective disorder market report are Allegan, Pfizer, Eli Lily, GlaxoSmithKline, Teva Pharmaceuticals, Bausch Health, Mylan, Johnson & Johnson, Novartis, Sanofi, Koninklije Philips, Beurer, Lucimed, Roche, Bayer, AbbVie, F. Hoffmann and Henry Schein, among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analystsunderstand competitive strengths and provide competitive analysis for each competitor separately.
- The Wire Times